These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Plasma prostaglandin E in patients with cancer with and without hypercalcemia. Robertson RP; Baylink DJ; Metz SA; Cummings KB J Clin Endocrinol Metab; 1976 Dec; 43(6):1330-5. PubMed ID: 1002818 [TBL] [Abstract][Full Text] [Related]
5. The pathogenesis of humoral hypercalcaemia of malignancy. Ralston SH Lancet; 1987 Dec; 2(8573):1443-6. PubMed ID: 2892002 [TBL] [Abstract][Full Text] [Related]
6. Increased prevalence of primary hyperparathyroidism in treated breast cancer. Fierabracci P; Pinchera A; Miccoli P; Conte PF; Vignali E; Zaccagnini M; Marcocci C; Giani C J Endocrinol Invest; 2001 May; 24(5):315-20. PubMed ID: 11407650 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms and treatment of hypercalcemia of malignancy. Clines GA Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221 [TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population. Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539 [TBL] [Abstract][Full Text] [Related]
9. A novel parathyroid hormone-related protein: role in pathology and physiology. Martin TJ; Ebeling PR Prog Clin Biol Res; 1990; 332():1-37. PubMed ID: 2184438 [TBL] [Abstract][Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
11. Hypercalcemia and cancer: an update. Murray TM; Josse RG; Heersche JN Can Med Assoc J; 1978 Oct; 119(8):915-20. PubMed ID: 367555 [TBL] [Abstract][Full Text] [Related]
12. Immunoreactive forms of circulating parathyroid hormone in primary and ectopic hyperparathyroidism. Benson RC; Riggs BL; Pickard BM; Arnaud CD J Clin Invest; 1974 Jul; 54(1):175-81. PubMed ID: 4834887 [TBL] [Abstract][Full Text] [Related]
16. Calcium metabolism in cancer. Studies using calcium isotopes and immunoassays for parathyroid hormone and calcitonin. Coombes RS; Ward MK; Greenberg PB; Hillyard CJ; Tulloch BR; Morrison R; Joplin GF Cancer; 1976 Nov; 38(5):2111-20. PubMed ID: 186180 [TBL] [Abstract][Full Text] [Related]
17. Exocrine pancreatic cancer with humoral hypercalcemia. Monno S; Nagata A; Homma T; Oguchi H; Kawa S; Kaji R; Furuta S Am J Gastroenterol; 1984 Feb; 79(2):128-32. PubMed ID: 6695885 [TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E and hypercalcemia in breast carcinoma: only a tumor marker? A need for perspective. Caro JF; Besarab A; Flynn JT Am J Med; 1979 Feb; 66(2):337-41. PubMed ID: 218452 [TBL] [Abstract][Full Text] [Related]
20. A study of prostaglandin E2, parathormone, and response to indomethacin in patients with hypercalcemia of malignancy. Brenner DE; Harvey HA; Lipton A; Demers L Cancer; 1982 Feb; 49(3):556-61. PubMed ID: 7059914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]